Xiaohui Pan

发表

Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from Klebsiella pneumoniae and comparison with a related Streptococcus pneumoniae complex

I. Laponogov, J. Narasimhan, G. Skamrova, 2016, Acta crystallographica. Section D, Structural biology.

Breakage-Reunion Domain of Streptococcus pneumoniae Topoisomerase IV: Crystal Structure of a Gram-Positive Quinolone Target

I. Laponogov, Cheng Yang, A. Achari, 2007, PloS one.

Ciprofloxacin Dimers Target Gyrase in Streptococcus pneumoniae

K. Gould, L. Fisher, Xiaohui Pan, 2004, Antimicrobial Agents and Chemotherapy.

Quinolone Resistance Mutations in Streptococcus pneumoniae GyrA and ParC Proteins: Mechanistic Insights into Quinolone Action from Enzymatic Analysis, Intracellular Levels, and Phenotypes of Wild-Type and Mutant Proteins

L. Fisher, Xiaohui Pan, G. Yague, 2001, Antimicrobial Agents and Chemotherapy.

DNA Gyrase and Topoisomerase IV Are Dual Targets of Clinafloxacin Action in Streptococcus pneumoniae

L. Fisher, Xiaohui Pan, X. Pan, 1998, Antimicrobial Agents and Chemotherapy.

Small-Colony Mutants of Staphylococcus aureus Allow Selection of Gyrase-Mediated Resistance to Dual-Target Fluoroquinolones

R. Taléns-Visconti, R. Manzo, F. Alovero, 2002, Antimicrobial Agents and Chemotherapy.

cDNA cloning of four Hsp genes from Agarophyton vermiculophyllum and transcription analysis in different phases

Xiaohui Pan, Hongyan Yang, Z. Sui, 2020, Marine Life Science & Technology.

Cleavable-Complex Formation by Wild-Type and Quinolone-Resistant Streptococcus pneumoniae Type II Topoisomerases Mediated by Gemifloxacin and Other Fluoroquinolones

K. Gould, L. Fisher, Xiaohui Pan, 2002, Antimicrobial Agents and Chemotherapy.

Streptococcus pneumoniae DNA Gyrase and Topoisomerase IV: Overexpression, Purification, and Differential Inhibition by Fluoroquinolones

L. Fisher, Xiaohui Pan, X. Pan, 1999, Antimicrobial Agents and Chemotherapy.

Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities.

L. Fisher, Xiaohui Pan, 2008, Methods in molecular medicine.

Grepafloxacin, a Dimethyl Derivative of Ciprofloxacin, Acts Preferentially through Gyrase in Streptococcus pneumoniae: Role of the C-5 Group in Target Specificity

L. Fisher, Xiaohui Pan, Julia E. Morris, 2002, Antimicrobial Agents and Chemotherapy.

Engineering the Specificity of Antibacterial Fluoroquinolones: Benzenesulfonamide Modifications at C-7 of Ciprofloxacin Change Its Primary Target in Streptococcus pneumoniae from Topoisomerase IV to Gyrase

R. Manzo, F. Alovero, L. Fisher, 2000, Antimicrobial Agents and Chemotherapy.

Mycobacterium tuberculosis DNA Gyrase: Interaction with Quinolones and Correlation with Antimycobacterial Drug Activity

V. Jarlier, L. Fisher, A. Aubry, 2004, Antimicrobial Agents and Chemotherapy.

Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.

Alexandra Aubry, L. Fisher, A. Aubry, 2009, The Journal of antimicrobial chemotherapy.

Target speciﬁcity of the new ﬂuoroquinolone besiﬂoxacin in Streptococcus pneumoniae , Staphylococcus aureus and Escherichia coli

L. Fisher, A. Aubry, S. Matrat, 2009 .

Analysis of dual active fluoroquinolones in Streptococcus pneumoniae.

K. Gould, L. Fisher, Xiaohui Pan, 2003, The Journal of antimicrobial chemotherapy.

Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases

I. Laponogov, K. McAuley, L. Fisher, 2009, Nature Structural &Molecular Biology.

Clerocidin selectively modifies the gyrase-DNA gate to induce irreversible and reversible DNA damage

M. Palumbo, L. Fisher, Xiaohui Pan, 2008, Nucleic acids research.

Novel Symmetric and Asymmetric DNA Scission Determinants for Streptococcus pneumoniae Topoisomerase IV and Gyrase Are Clustered at the DNA Breakage Site*

G. Capranico, K. Gould, M. Palumbo, 2005, Journal of Biological Chemistry.